Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Prognostic impact of ventilation-perfusion defects and pulmonary diffusing capacity after single lung transplantation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cardiorespiratory responses to high intensity skeletal muscle metaboreflex activation in chronic obstructive pulmonary disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The age-related reduction in cerebral blood flow affects vertebral artery more than internal carotid artery blood flow

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Myocardial perfusion assessed with cardiac computed tomography in women without coronary heart disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. I-MIBG imaging for detection of anthracycline-induced cardiomyopathy

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Alfa-1 Antitrypsinmangel

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

BACKGROUND: Ventilation-perfusion (VQ) scintigraphy and lung function testing are often used to assess allograft function after single lung transplantation (SLTX). However, it is unknown whether allograft defects on VQ scintigraphy presage all-cause mortality after SLTX.

OBJECTIVE: To investigate whether allograft defects on VQ scintigraphy portend poorer lung function and increased mortality after SLTX.

METHODS: We retrospectively identified 45 consecutive patients in which a VQ scintigraphy was performed as part of the routine workup 12 weeks after SLTX. VQ scintigraphies were scored for matched and mismatched perfusion defects in the allograft. Lung function testing was performed according to established guidelines six months after SLTX. Time to all-cause mortality was the endpoint.

RESULTS: 19 (42%) patients had matched VQ defects. After a median follow-up of 4.1 (IQR 1.5-7.9) years since SLTX, 35 (78%) had died. Those with matched defects in the allograft had lower diffusing capacity (mean 42 [SD 14] versus mean 54 [SD 18] % of predicted, p < .05) and increased mortality (univariable HR 2.06, 95% CI: 1.05-4.06, p = .04). However, in multivariate analysis, only lower post-transplantation diffusing capacity remained associated with mortality (HR 1.08, 95% CI: 1.02-1.30 per % lower diffusing capacity of predicted, p = .003).

CONCLUSION: In SLTX patients, a lower diffusing capacity appeared to explain the increased mortality among those with matched VQ defects in the allograft.

OriginalsprogEngelsk
TidsskriftClinical Physiology and Functional Imaging
Vol/bind41
Udgave nummer2
Sider (fra-til)221-225
Antal sider5
ISSN1475-0961
DOI
StatusUdgivet - mar. 2021

Bibliografisk note

© 2020 Scandinavian Society of Clinical Physiology and Nuclear Medicine.

ID: 61984034